Adjustable nasal devices

• US 8,240,309 B2
• Filed: 11/16/2007
• Issued: 08/14/2012
• Est. Priority Date: 11/16/2006
• Status: Active Grant

• Current Assignee: Theravent, Inc
• Original Assignee: Ventus Medical, Inc.
• Inventors: Doshi, Rajiv, Loomas, Bryan, Sather, Elliot, Servaites, Jeffrey W., Lebas, Sandrine, Myall, Patrick A., Kobeli, Lea
• Primary Examiner(s): Yu, Justine
• Assistant Examiner(s): Louis, LaToya M.
• Application Number:
  US11/941,915
• Publication Number:
  US 20080178874A1
• Time in Patent Office: 1,733 Days
• Field of Search: 128/200.24, 128/203.22, 128/206.11, 128/206.21, 128/207.13, 128/207.18, 606/199
• US Class Current: 128/207.18
• CPC Class Codes: A61F 5/08 Devices for correcting deformities of the nose ; Devices for enlarging the nostril, e.g. for breathing improvement

Abstract

Described herein are adjustable whole-nose nasal devices having a first passageway for communication with a first nasal passage and a second passageway for communication with a second nasal passage, an airflow resistor that inhibits expiration more than inspiration, and an adjustable connector. The adjustable connector may include one or more adjustable joints or regions that allow the whole-nose device to conform to the spacing between a subject'"'"'s nostrils, and/or the orientation and angle of the subject'"'"'s nostrils. Also described herein are whole-nose devices having a single airflow resistor communicating with both of a subject'"'"'s nasal passages. Methods of treating a disorder using the whole-nose nasal devices are also described.

Claims

1. A nasal device adapted to be secured in communication with a subject'"'"'s nasal passage, comprising:

a first passageway through a first body, wherein the first passageway is configured to fluidly connect with a subject'"'"'s first nasal passage;

a second passageway through a second body, wherein the second passageway is configured to fluidly connect to a subject'"'"'s second nasal passage;

a passive airflow resistor configured to be secured outside of the subject'"'"'s nose and connect with both the first passageway and the second passageway, wherein the airflow resistor is configured to increase the resistance to exhalation through the nasal device more than inhalation through the nasal device to create expiratory positive airway pressure;

a holdfast configured to secure the nasal device in communication with the subject'"'"'s nasal passages; and

a connector connecting the first body and the second body.

2. The device of claim 1, wherein the connector is a telescoping joint, a sliding joint, or a continuously flexible joint.

3. The device of claim 1, wherein the connector is selected from the group consisting of:

a bendable wire, a spring, an accordion tube.

4. The device of claim 1, wherein the holdfast is part of the connector.

5. A whole-nose nasal device comprising:

a passageway configured to receive airflow from both of a subject'"'"'s nasal passages so that nasal breathing, but not oral breathing, will occur through the passageway; and

a passive airflow resistor in a portion of the passageway located outside of the subject'"'"'s nasal passages, wherein the airflow resistor is configured to inhibit expiration through the nasal device more than inspiration through the nasal device to create expiratory positive airway pressure.

6. The device of claim 5, further comprising a holdfast configured to at least partly secure the device to the subject'"'"'s nose so that the passageway is in communication with both of the subject'"'"'s nasal passages.

7. A method of treating a disorder using a nasal device, wherein the nasal device includes a first passageway configured to communicate with a subject'"'"'s right nasal passage and a second passageway configured to communicate with the subject'"'"'s left nasal passage, a passive airflow resistor located outside of the subject'"'"'s nasal passages, wherein the passive airflow resistor receives airflow from both the first and second passageways and inhibits expiration through the nasal device more than it inhibits inhalation through the nasal device to create expiratory positive airway pressure, and a connector, wherein the method comprises:

applying the nasal device so that the first passageway is in communication with the subject'"'"'s right nasal passage and the second passageway is in communication with the subject'"'"'s left nasal passage while the passive airflow resistor is outside of the subject'"'"'s nasal passages; and

securing the nasal device to the subject.

8. The method of claim 7, wherein the disorder to be treated is selected from the list consisting of:

respiratory disorders, sleep disorders, gastroenterologic disorders, and cardiovascular disorders.

9. A method of treating a disorder using a whole-nose nasal device, wherein the whole-nose nasal device includes a body having a first passageway and a second passageway;

and a passive airflow resistor in fluid communication with the first and second passageways, wherein the airflow resistor is configured to inhibit expiration through the nasal device more than inspiration through the nasal device to create expiratory positive airway pressure, the method comprising;

securing the first passageway of the nasal device in communication with the subject'"'"'s right nasal passage and the second passageway of the nasal device in communication with the subject'"'"'s left nasal passage while the passive airflow resistor is outside of the subject'"'"'s nasal passages; and

inhibiting nasal expiration more than nasal inspiration.